Cardiff Oncology Long Term Deferred Assets (Quarterly) Insights

Cardiff Oncology, Inc. (CRDF)

2.81 -0.07 (-2.43%) USD | NASDAQ | Jan 20, 16:00

2.81 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for CRDF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Agenus, Inc.	--
AIM ImmunoTech, Inc.	--
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	Upgrade
Armata Pharmaceuticals, Inc.	--